M&A / Deals China’s Haisco forms immunology biotech with up to $1.5B from American VCs BioSpaceHaisco Pharmaceutical Group has been on a deal hot streak this year, inking major deals with Eli Lilly, AbbVie and more.Immunology & InflammationRead full story pharminent August 25, 2026 (Last updated: August 26, 2026) BioSpace Haisco Pharmaceutical Group has been on a deal hot streak this year, inking major deals with Eli Lilly, AbbVie and more. Immunology & Inflammation Read full story Post navigation Previous: Expanded US Imaavy approval first ever for wAIHANext: Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test Related Stories M&A / Deals Roche commits to lean-mass preservation with Hanmi obesity deal pharminent August 24, 2026 M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026
